Photodynamic Therapy For Onychomycosis: An Open Label Study
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Clinical and mycological diagnosis \[by potassium hydroxide (KOH) stain\] of onychomycosis
Locations
United States
Texas
Arlington Center for Dermatology
RECRUITING
Arlington
Houston Skin
NOT_YET_RECRUITING
Houston
Houston Skin
NOT_YET_RECRUITING
Webster
Contact Information
Primary
Stephen Tyring, MD, PhD, MBA
Stephen.K.Tyring@uth.tmc.edu
(281) 333-3376
Backup
Luke Moore
luke.c.moore@uth.tmc.edu
(817) 795-7546
Time Frame
Start Date: 2026-08-10
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 5
Treatments
Experimental: Photodynamic Therapy
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston